Literature DB >> 25444903

Expression of Sox2 in breast cancer cells promotes the recruitment of M2 macrophages to tumor microenvironment.

Wenjun Mou1, Yingxi Xu2, Yujie Ye2, Si Chen2, Xuefei Li3, Kangzi Gong2, Yanhua Liu2, Yanan Chen2, Xiru Li4, Yaping Tian5, Rong Xiang6, Na Li7.   

Abstract

Transcriptional factor Sox2 promotes tumor metastasis; however its regulatory effect on tumor-associated macrophages (TAMs, M2 phenotype) has not been defined. This study disclosed concomitant expression of TAMs marker-CD163 with SOX2 in human breast cancer and showed that Sox2 in breast cancer cells promotes recruitment of TAMs with altered expression of multiple chemokines, including MIP-1α, ICAM-1 etc. and activation of Stat3 and NF-κB signalings. In addition, TAMs rescued the compromised lung metastasis induced by Sox2 silencing in breast cancer cells. Together, this study documented that Sox2 plays an important role in recruiting TAMs and promotes tumor metastasis in a TAMs dependent manner.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CD163; Sox2; Tumor microenvironment; Tumor-associated macrophages

Mesh:

Substances:

Year:  2014        PMID: 25444903     DOI: 10.1016/j.canlet.2014.11.004

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  21 in total

Review 1.  Nanoparticle Interactions with the Tumor Microenvironment.

Authors:  Yanyan Huai; Md Nazir Hossen; Stefan Wilhelm; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Bioconjug Chem       Date:  2019-09-05       Impact factor: 4.774

2.  Sox2 Communicates with Tregs Through CCL1 to Promote the Stemness Property of Breast Cancer Cells.

Authors:  Yingxi Xu; Xiaoli Dong; Pingping Qi; Yujie Ye; Wenzhi Shen; Liang Leng; Lina Wang; Xuefei Li; Xiaohe Luo; Yanan Chen; Peiqing Sun; Rong Xiang; Na Li
Journal:  Stem Cells       Date:  2017-12       Impact factor: 6.277

3.  Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.

Authors:  Saeid Zanganeh; Gregor Hutter; Ryan Spitler; Olga Lenkov; Morteza Mahmoudi; Aubie Shaw; Jukka Sakari Pajarinen; Hossein Nejadnik; Stuart Goodman; Michael Moseley; Lisa Marie Coussens; Heike Elisabeth Daldrup-Link
Journal:  Nat Nanotechnol       Date:  2016-09-26       Impact factor: 39.213

4.  Antitumor properties of triptolide: phenotype regulation of macrophage differentiation.

Authors:  Han Li; Liping Li; Huifang Mei; Guofeng Pan; Xinzhi Wang; Xin Huang; Tao Wang; Zhenzhou Jiang; Luyong Zhang; Lixin Sun
Journal:  Cancer Biol Ther       Date:  2019-10-30       Impact factor: 4.742

Review 5.  SOX factors as cell-state regulators in the mammary gland and breast cancer.

Authors:  Yu Liu; Wenjun Guo
Journal:  Semin Cell Dev Biol       Date:  2021-02-12       Impact factor: 7.499

6.  SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling.

Authors:  Hui Gao; Chunyuan Teng; Wenjing Huang; Jianjun Peng; Chunbo Wang
Journal:  Int J Mol Sci       Date:  2015-09-08       Impact factor: 5.923

7.  MUC1 induces M2 type macrophage influx during postpartum mammary gland involution and triggers breast cancer.

Authors:  Yuan Li; Zhi Pang; Xinran Dong; Xiaodong Liao; Huayun Deng; Chunhua Liao; Yahui Liao; Guoqiang Chen; Lei Huang
Journal:  Oncotarget       Date:  2017-12-15

8.  STIM1 accelerates cell senescence in a remodeled microenvironment but enhances the epithelial-to-mesenchymal transition in prostate cancer.

Authors:  Yingxi Xu; Shu Zhang; Haiying Niu; Yujie Ye; Fen Hu; Si Chen; Xuefei Li; Xiaohe Luo; Shan Jiang; Yanhua Liu; Yanan Chen; Junying Li; Rong Xiang; Na Li
Journal:  Sci Rep       Date:  2015-08-10       Impact factor: 4.379

Review 9.  Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer.

Authors:  Bhagelu R Achyut; Ali S Arbab
Journal:  Onco Targets Ther       Date:  2016-03-01       Impact factor: 4.147

Review 10.  Expression of sex-determining region Y-box protein 2 in breast cancer and its clinical significance.

Authors:  Xuesong Feng; Mingqian Lu
Journal:  Saudi Med J       Date:  2017-07       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.